表紙
市場調查報告書

3D生物印刷的全球市場預測 2021年:微押出、噴墨、雷射輔助、磁3D生物印刷

3D Bioprinting Market by Technology (Microextrusion, Inkjet, Laser, Magnetic), Material (Cells, Hydrogels, Extracellular Matrices, Biomaterials), Application (Clinical (Bone, Cartilage, Skin), Research (Regenerative Medicine)) - Global Forecasts to 2021

出版商 MarketsandMarkets 商品編碼 432880
出版日期 內容資訊 英文 145 Pages
訂單完成後即時交付
價格
Back to Top
3D生物印刷的全球市場預測 2021年:微押出、噴墨、雷射輔助、磁3D生物印刷 3D Bioprinting Market by Technology (Microextrusion, Inkjet, Laser, Magnetic), Material (Cells, Hydrogels, Extracellular Matrices, Biomaterials), Application (Clinical (Bone, Cartilage, Skin), Research (Regenerative Medicine)) - Global Forecasts to 2021
出版日期: 2017年02月01日內容資訊: 英文 145 Pages
簡介

全球3D生物印刷市場規模,預計從2016年到2021年以26.5%的年複合成長率發展,到2021年達到13億3,260萬美元。3D生物印刷市場,由於全球性器官移植的需求擴大而受到促進。加上,3D生物印刷的領域的R&D增加,3D生物印刷研究支援的公共、民間投資的增加,及開發藥劑中3D生物印刷的利用擴大,支撐著該市場的成長。另一方面,生醫材料來源產品的限制及社會、倫理性的疑慮成為該市場的主要課題。

本報告提供全球3D生物印刷市場調查,各技術、材料、用途,及各地區的市場規模的分析與預測,競爭環境分析,及主要企業簡介等系統性資訊。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

  • 3D生物印刷:市場概要
  • 地區分析:各3D生物印刷市場,技術
  • 3D生物印刷市場規模:各材料
  • 3D生物印刷市場規模:各應用領域
  • 3D生物印刷市場地區概要

第5章 市場概要

  • 簡介
  • 市場動態
    • 成長推動因素
    • 阻礙成長要素
    • 市場機會
    • 課題

第6章 產業考察

  • 簡介
  • 3D生物印刷的方法
    • 生物模擬
    • 自主的自組裝
    • 小細胞的結構要素
  • 3D生物印刷的專利形勢
  • 產業趨勢

第7章 3D生物印刷市場:各技術

  • 簡介
  • 磁3D生物印刷
  • 雷射輔助生物印刷
  • 噴墨3D生物印刷
  • 微擠壓

第8章 3D生物印刷市場:各材料

  • 簡介
  • 水凝膠
  • 細胞外矩陣
  • 生物細胞
  • 其他生醫材料

第9章 3D生物印刷市場:各用途

  • 簡介
  • 臨床用途
    • 皮膚
    • 骨 軟骨
    • 血管
  • 研究用途
    • 藥物研究
    • 再生醫療
    • 培養3D細胞

第10章 3D生物印刷市場:各地區

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 其他 (ROW)

第11章 競爭環境

  • 概要
  • 市場排行榜分析
  • 競爭情形、趨勢

第12章 企業簡介

  • 簡介
  • ORGANOVO HOLDINGS, INC.
  • ENVISIONTEC GMBH
  • NANO3D BIOSCIENCES, INC.
  • CYFUSE BIOMEDICAL K.K.
  • REGENHU LTD.
  • ASPECT BIOSYSTEMS LTD.
  • BIOBOTS
  • CELLINK
  • GESIM
  • POIETIS
  • REGENOVO BIOTECHNOLOGY CO., LTD.
  • 3DYNAMIC SYSTEMS LTD.

第13章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: BT 4971

The 3D bioprinting market is expected to reach USD 1,332.6 million by 2021, at a CAGR of 26.5% from 2016 to 2021.

The 3D bioprinting market is primarily driven by the rising demand for organ transplantation across the globe. In addition, growing R&D in the field of 3D bioprinting, increasing public and private investments to support 3D bioprinting research, and rising use of 3D bioprinting in drug discovery are supporting the growth of this market. On the other hand, limitations of biomaterial-based products and socio-ethical concerns are the major challenges in this market.

In this report, the 3D bioprinting market has been segmented on the basis of technology, applications (clinical and research applications), materials (living cells, hydrogels, extracellular matrices, and other biomaterials), and regions (North America, Europe, APAC, and the RoW). By technology, the global 3D bioprinting market is segmented into four categories, namely, microextrusion, laser-assisted, inkjet, and magnetic 3D bioprinting. The microextrusion 3D bioprinting market is estimated to command the largest share of the global market in 2016, due to its high affordability and simple setup process.

Geographically, North America (comprising the U.S. and Canada) is expected to command the largest share of the 3D bioprinting market in 2016, followed by Europe. Increasing government initiatives and rising demand for organ transplants are the major factors driving market growth in North America. However, the presence of a stringent regulatory process for the approval of 3D bioprinting products is a major factor restraining the growth of this regional segment.

The 3D bioprinting market consists of a number of big, medium-sized, and small companies. As of 2015, the syringes market is dominated by Organovo Holdings Inc. (U.S.), EnvisionTEC GmbH (Germany), and Nano3D Biosciences, Inc. (U.S.). Product launches, development, and commercialization; agreements; collaboration; and partnerships were the major strategies adopted by most of the market players between 2013 and 2016 to achieve growth in the 3D bioprinting market.

Research Coverage:

This report studies the 3D bioprinting market based on technology, application, and material. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends, prospects, and contributions to the total market. The report forecasts the revenue of the market segments with respect to four main regions.

Reasons to Buy the Report:

This research report focuses on various levels of analysis-industry trends, market ranking of top players, and company profiles-which together discuss basic views on the competitive landscape, emerging and high-growth segments of the 3D bioprinting market, and high-growth regions and their respective drivers, restraints, challenges, and opportunities.

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms in garnering a greater market share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies for strengthening its market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on products and services offered by major players in the 3D bioprinting market. The report analyzes the 3D bioprinting market based on technology, application, material, and region
  • Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and product launches in the 3D bioprinting market
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various 3D bioprinting products across geographies
  • Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the 3D bioprinting market
  • Competitive Assessment: In-depth assessment of market shares, strategies, products & services, distribution networks, and manufacturing capabilities of leading players in the 3D bioprinting market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
  • 1.4. MARKETS COVERED
  • 1.5. YEARS CONSIDERED FOR THE STUDY
  • 1.6. CURRENCY
  • 1.7. LIMITATIONS
  • 1.8. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH METHODOLOGY STEPS
    • 2.1.1. SECONDARY AND PRIMARY RESEARCH METHODOLOGY
      • 2.1.1.1. Secondary research
      • 2.1.1.2. Key data from secondary sources
      • 2.1.1.3. Primary research
      • 2.1.1.4. Key data from primary sources
      • 2.1.1.5. Key Industry Insights
  • 2.2. MARKET SIZE ESTIMATION METHODOLOGY
  • 2.3. RESEARCH DESIGN
  • 2.4. MARKET DATA VALIDATION AND TRIANGULATION
  • 2.5. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

  • 3.1. INTRODUCTION
  • 3.2. CONCLUSION

4. PREMIUM INSIGHTS

  • 4.1. 3D BIOPRINTING: MARKET OVERVIEW
  • 4.2. GEOGRAPHIC ANALYSIS: 3D BIOPRINTING MARKET, BY TECHNOLOGY (2016)
  • 4.3. 3D BIOPRINTING MARKET SIZE, BY MATERIAL, 2016 VS. 2021(USD MILLION)
  • 4.4. 3D BIOPRINTING MARKET SIZE, BY APPLICATION, 2016 VS. 2021(USD MILLION)
  • 4.5. GEOGRAPHIC SNAPSHOT OF THE 3D BIOPRINTING MARKET

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. Growing demand for organ transplantation
      • 5.2.1.2. Rise in public and private funding to support 3D bioprinting research activities
      • 5.2.1.3. Increasing use of 3D bioprinting in the drug discovery process
      • 5.2.1.4. Growing focus of market players on 3D bioprinting
    • 5.2.2. RESTRAINTS
      • 5.2.2.1. Lack of regulatory guidelines governing 3D bioprinting
      • 5.2.2.2. Dearth of trained professionals
    • 5.2.3. OPPORTUNITIES
      • 5.2.3.1. Increasing stem cell research
      • 5.2.3.2. Growing awareness related to 3D bioprinting
      • 5.2.3.3. Rising adoption of 3D bioprinting in the cosmetic industry
    • 5.2.4. CHALLENGES
      • 5.2.4.1. Socio-ethical concerns related to the use of 3D bioprinted products
      • 5.2.4.2. Limitations of biomaterial-based products
      • 5.2.4.3. Lack of complete automation

6. INDUSTRY INSIGHTS

  • 6.1. INTRODUCTION
  • 6.2. 3D BIOPRINTING APPROACHES
    • 6.2.1. BIOMIMICRY
    • 6.2.2. AUTONOMOUS SELF-ASSEMBLY
    • 6.2.3. MINI-TISSUE BUILDING BLOCKS
  • 6.3. 3D BIOPRINTING PATENT LANDSCAPE
  • 6.4. INDUSTRY TRENDS
    • 6.4.1. FUNDING AND INVESTMENTS
    • 6.4.2. PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS
    • 6.4.3. CONFERENCES AND SYMPOSIUMS

7. 3D BIOPRINTING MARKET, BY TECHNOLOGY

  • 7.1. INTRODUCTION
  • 7.2. MAGNETIC 3D BIOPRINTING
  • 7.3. LASER-ASSISTED BIOPRINTING
  • 7.4. INKJET 3D BIOPRINTING
  • 7.5. MICROEXTRUSION BIOPRINTING

8. 3D BIOPRINTING MARKET, BY MATERIAL

  • 8.1. INTRODUCTION
  • 8.2. HYDROGELS
  • 8.3. EXTRACELLULAR MATRICES
  • 8.4. LIVING CELLS
  • 8.5. OTHER BIOMATERIALS

9. 3D BIOPRINTING MARKET, BY APPLICATION

  • 9.1. INTRODUCTION
  • 9.2. CLINICAL APPLICATIONS
    • 9.2.1. SKIN
    • 9.2.2. BONE & CARTILAGE
    • 9.2.3. BLOOD VESSELS
  • 9.3. RESEARCH APPLICATIONS
    • 9.3.1. DRUG RESEARCH
    • 9.3.2. REGENERATIVE MEDICINE
    • 9.3.3. 3D CELL CULTURE

10. 3D BIOPRINTING MARKET, BY REGION

  • 10.1. INTRODUCTION
  • 10.2. NORTH AMERICA
    • 10.2.1. U.S.
    • 10.2.2. CANADA
  • 10.3. EUROPE
    • 10.3.1. GERMANY
    • 10.3.2. FRANCE
    • 10.3.3. U.K.
    • 10.3.4. REST OF EUROPE (ROE)
  • 10.4. ASIA-PACIFIC
    • 10.4.1. JAPAN
    • 10.4.2. CHINA
    • 10.4.3. INDIA
    • 10.4.4. REST OF ASIA-PACIFIC
  • 10.5. REST OF THE WORLD (ROW)

11. COMPETITIVE LANDSCAPE

  • 11.1. OVERVIEW
  • 11.2. MARKET RANKING ANALYSIS
  • 11.3. COMPETITIVE SITUATION AND TRENDS
    • 11.3.1. AGREEMENTS, PARTNERSHIPS, & COLLABORATIONS
    • 11.3.2. PRODUCT LAUNCHES, DEVELOPMENTS, AND COMMERCIALIZATION
    • 11.3.3. PRODUCT SHOWCASES, EXHIBITIONS, AND PRESENTATIONS
    • 11.3.4. FUNDING
    • 11.3.5. OTHER STRATEGIES

12. COMPANY PROFILES (Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*

  • 12.1. INTRODUCTION
  • 12.2. ORGANOVO HOLDINGS, INC.
  • 12.3. ENVISIONTEC GMBH
  • 12.4. NANO3D BIOSCIENCES, INC.
  • 12.5. CYFUSE BIOMEDICAL K.K.
  • 12.6. REGENHU LTD.
  • 12.7. ASPECT BIOSYSTEMS LTD.
  • 12.8. BIOBOTS
  • 12.9. CELLINK
  • 12.10. GESIM
  • 12.11. POIETIS
  • 12.12. REGENOVO BIOTECHNOLOGY CO., LTD.
  • 12.13. 3DYNAMIC SYSTEMS LTD.

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.

13. APPENDIX

  • 13.1. DISCUSSION GUIDE
  • 13.2. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 13.4. AVAILABLE CUSTOMIZATIONS
  • 13.5. RELATED REPORTS
  • 13.6. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: 3D BIOPRINTING PATENTS, 2015-2016
  • TABLE 2: 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 3: MAGNETIC 3D BIOPRINTING MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 4: LASER-ASSISTED 3D BIOPRINTING MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 5: INKJET 3D BIOPRINTING MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 6: MICROEXTRUSION 3D BIOPRINTING MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 7: 3D BIOPRINTING MARKET SIZE, BY MATERIAL, 2014-2021 (USD MILLION)
  • TABLE 8: HYDROGELS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 9: EXTRACELLULAR MATRICES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 10: LIVING CELLS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 11: OTHER BIOMATERIALS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 12: 3D BIOPRINTING MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 13: CLINICAL APPLICATIONS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 14: CLINICAL APPLICATIONS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 15: SKIN BIOPRINTING MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 16: BONE & CARTILAGE BIOPRINTING MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 17: BLOOD VESSEL BIOPRINTING MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 18: RESEARCH APPLICATIONS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 19: RESEARCH APPLICATIONS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 20: DRUG RESEARCH MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 21: REGENERATIVE MEDICINE MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 22: 3D CELL CULTURE MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 23: 3D BIOPRINTING MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 24: NORTH AMERICA: 3D BIOPRINTING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 25: NORTH AMERICA: 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 26: NORTH AMERICA: 3D BIOPRINTING MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 27: NORTH AMERICA: 3D BIOPRINTING MARKET SIZE, BY MATERIAL, 2014-2021 (USD MILLION)
  • TABLE 28: U.S.: 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 29: U.S.: 3D BIOPRINTING MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 30: U.S.: 3D BIOPRINTING MARKET SIZE, BY MATERIAL, 2014-2021 (USD MILLION)
  • TABLE 31: CANADA: 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 32: CANADA: 3D BIOPRINTING MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 33: CANADA: 3D BIOPRINTING MARKET SIZE, BY MATERIAL, 2014-2021 (USD MILLION)
  • TABLE 34: EUROPE: 3D BIOPRINTING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 35: EUROPE: 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 36: EUROPE: 3D BIOPRINTING MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 37: EUROPE: 3D BIOPRINTING MARKET SIZE, BY MATERIAL, 2014-2021 (USD MILLION)
  • TABLE 38: GERMANY: 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 39: GERMANY: 3D BIOPRINTING MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 40: GERMANY: 3D BIOPRINTING MARKET SIZE, BY MATERIAL, 2014-2021 (USD MILLION)
  • TABLE 41: FRANCE: 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 42: FRANCE: 3D BIOPRINTING MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 43: FRANCE: 3D BIOPRINTING MARKET SIZE, BY MATERIAL, 2014-2021 (USD MILLION)
  • TABLE 44: U.K.: 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 45: U.K.: 3D BIOPRINTING MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 46: U.K.: 3D BIOPRINTING MARKET SIZE, BY MATERIAL, 2014-2021 (USD MILLION)
  • TABLE 47: ROE: 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 48: ROE: 3D BIOPRINTING MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 49: ROE: 3D BIOPRINTING MARKET SIZE, BY MATERIAL, 2014-2021 (USD MILLION)
  • TABLE 50: ASIA-PACIFIC: 3D BIOPRINTING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 51: ASIA-PACIFIC: 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 52: ASIA-PACIFIC: 3D BIOPRINTING MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 53: ASIA-PACIFIC: 3D BIOPRINTING MARKET SIZE, BY MATERIAL, 2014-2021 (USD MILLION)
  • TABLE 54: JAPAN: 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 55: JAPAN: 3D BIOPRINTING MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 56: JAPAN: 3D BIOPRINTING MARKET SIZE, BY MATERIAL, 2014-2021 (USD MILLION)
  • TABLE 57: CHINA: 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 58: CHINA: 3D BIOPRINTING MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 59: CHINA: 3D BIOPRINTING MARKET SIZE, BY MATERIAL, 2014-2021 (USD MILLION)
  • TABLE 60: INDIA: 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 61: INDIA: 3D BIOPRINTING MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 62: INDIA: 3D BIOPRINTING MARKET SIZE, BY MATERIAL, 2014-2021 (USD MILLION)
  • TABLE 63: ROAPAC: 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 64: ROAPAC: 3D BIOPRINTING MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 65: ROAPAC: 3D BIOPRINTING MARKET SIZE, BY MATERIAL, 2014-2021 (USD MILLION)
  • TABLE 66: ROW: 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 67: ROW: 3D BIOPRINTING MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 68: ROW: 3D BIOPRINTING MARKET SIZE, BY MATERIAL, 2014-2021 (USD MILLION)
  • TABLE 69: AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS, 2013-2016
  • TABLE 70: TOP 5 PRODUCT LAUNCHES, DEVELOPMENTS, AND COMMERCIALIZATION, 2013-2016
  • TABLE 71: PRODUCT SHOWCASES, EXHIBITIONS, AND PRESENTATIONS, 2013-2016
  • TABLE 72: TOP 5 FUNDING, 2013-2016
  • TABLE 73: OTHER STRATEGIES, 2013-2016
  • TABLE 74: PRODUCT MIX OF THE 3D BIOPRINTER MARKET PLAYERS

LIST OF FIGURES

  • FIGURE 1: GLOBAL 3D BIOPRINTING MARKET: RESEARCH METHODOLOGY STEPS
  • FIGURE 2: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 3: RESEARCH METHODOLOGY: BOTTOM-UP APPROACH
  • FIGURE 4: RESEARCH METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 5: DATA TRIANGULATION METHODOLOGY
  • FIGURE 6: DATA TRIANGULATION METHODOLOGY
  • FIGURE 7: GLOBAL 3D BIOPRINTING MARKET, BY TECHNOLOGY
  • FIGURE 8: GLOBAL 3D BIOPRINTING MARKET, BY APPLICATION
  • FIGURE 9: GLOBAL 3D BIOPRINTING MARKET, BY MATERIAL
  • FIGURE 10: GEOGRAPHIC SNAPSHOT OF THE GLOBAL 3D BIOPRINTING MARKET
  • FIGURE 11: RISING DEMAND FOR ORGAN TRANSPLANTATION IS DRIVING GROWTH IN THE 3D BIOPRINTING MARKET
  • FIGURE 12: MICROEXTRUSION 3D BIOPRINTING TO DOMINATE THE GLOBAL 3D BIOPRINTING MARKET IN 2016
  • FIGURE 13: LIVING CELLS TO COMMAND THE LARGEST SHARE IN THE 3D BIOPRINTING MARKET IN 2016
  • FIGURE 14: RESEARCH APPLICATIONS WILL CONTINUE TO DOMINATE THE GLOBAL 3D BIOPRINTING MARKET IN 2021
  • FIGURE 15: NORTH AMERICA TO COMMAND THE LARGEST SHARE IN THE GLOBAL 3D BIOPRINTING MARKET IN 2016
  • FIGURE 16: 3D BIOPRINTING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 17: MICROEXTRUSION 3D BIOPRINTING SEGMENT TO WITNESS HIGH GROWTH DURING THE FORECAST PERIOD
  • FIGURE 18: ASIA-PACIFIC TO WITNESS HIGH GROWTH DURING THE FORECAST PERIOD
  • FIGURE 19: NORTH AMERICA TO HOLD A MAJOR SHARE IN THE LASER-ASSISTED 3D BIOPRINTING MARKET
  • FIGURE 20: ASIA-PACIFIC TO WITNESS HIGH GROWTH DURING THE FORECAST PERIOD
  • FIGURE 21: NORTH AMERICA TO HOLD A MAJOR SHARE IN THE MICROEXTRUSION 3D BIOPRINTING MARKET
  • FIGURE 22: LIVING CELLS SEGMENT TO REGISTER HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 23: NORTH AMERICA TO HOLD THE LARGEST SHARE IN THE HYDROGELS MARKET, IN 2016 AND 2021
  • FIGURE 24: ASIA-PACIFIC SEGMENT TO REGISTER HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 25: NORTH AMERICA TO HOLD THE LARGEST SHARE IN THE LIVING CELLS MARKET DURING THE FORECAST PERIOD
  • FIGURE 26: NORTH AMERICA TO HOLD LARGEST SHARE OF THE OTHER BIOMATERIALS MARKET IN 2016
  • FIGURE 27: RESEARCH APPLICATIONS SEGMENT TO WITNESS HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 28: SKIN SEGMENT TO REGISTER HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 29: NORTH AMERICA TO COMMAND LARGEST SHARE DURING THE FORECAST PERIOD
  • FIGURE 30: DRUG RESEARCH SEGMENT TO REGISTER HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 31: ASIA-PACIFIC TO WITNESS HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 32: 3D BIOPRINTING MARKET: GROWTH FORECAST, BY REGION (2016-2021)
  • FIGURE 33: NORTH AMERICA: 3D BIOPRINTING MARKET SNAPSHOT
  • FIGURE 34: EUROPE: 3D BIOPRINTING MARKET SNAPSHOT
  • FIGURE 35: APAC: 3D BIOPRINTING MARKET SNAPSHOT
  • FIGURE 36: LEADING MARKET PLAYERS ADOPTED AGREEMENT, COLLABORATION, AND PARTNERSHIP AS THEIR KEY GROWTH STRATEGY OVER THE LAST THREE YEARS (2013-2016)
  • FIGURE 37: GLOBAL 3D BIOPRINTING MARKET RANKING, BY KEY PLAYER, 2015
  • FIGURE 38: BATTLE FOR MARKET SHARE: AGREEMENT, COLLABORATION, AND PARTNERSHIP WAS THE KEY STRATEGY ADOPTED BY MARKET PLAYERS
  • FIGURE 39: COMPANY SNAPSHOT: ORGANOVO HOLDINGS, INC.
Back to Top